Deletion of the S1P receptor S1P3 attenuates macrophage-driven inflammation in atherosclerotic lesions of S1P3-/-/ApoE-/- double knockout mice

被引:0
|
作者
Keul, P. [1 ]
Lucke, S. [1 ]
Lipinski, K. Von Wnuck [1 ]
Graeler, M. [2 ]
Heusch, G. [1 ]
Levkau, B. [1 ]
机构
[1] Univ Essen Gesamthsch, Sch Med, Inst Pathophysiol, Essen, Germany
[2] Hannover Med Sch, D-3000 Hannover, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:159 / 159
页数:1
相关论文
共 50 条
  • [31] A practical process for the preparation of [32P]S1P and binding assay for S1P receptor ligands
    Rosenberg, Adam J.
    Liu, Hui
    Tu, Zhude
    APPLIED RADIATION AND ISOTOPES, 2015, 102 : 5 - 9
  • [32] Short Periods of Hypoxia Upregulate Sphingosine Kinase 1 and Increase Vasodilation of Arteries to Sphingosine 1-Phosphate (S1P) via S1P3
    Alganga, H.
    Almabrouk, T. A. M.
    Katwan, O. J.
    Daly, C. J.
    Pyne, S.
    Pyne, N. J.
    Kennedy, S.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 371 (01): : 63 - 74
  • [33] Knock Out of S1P3 Receptor Signaling Attenuates Inflammation and Fibrosis in Bleomycin-Induced Lung Injury Mice Model
    Murakami, Ken
    Kohno, Masataka
    Kadoya, Masatoshi
    Nagahara, Hidetake
    Fujii, Wataru
    Seno, Takahiro
    Yamamoto, Aihiro
    Oda, Ryo
    Fujiwara, Hiroyoshi
    Kubo, Toshikazu
    Morita, Satoshi
    Nakada, Hiroshi
    Hla, Timothy
    Kawahito, Yutaka
    PLOS ONE, 2014, 9 (09):
  • [34] Sphingosine 1-phosphate (s1p) inhibits astrocytic glutamate uptake through s1p receptor 2 (S1P2)
    Jonnalagadda, D.
    Kihara, Y.
    Rivera, R.
    Chun, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 591 - 591
  • [35] Novel Selective Allosteric and Bitopic Ligands for the S1P3 Receptor
    Jo, Euijung
    Bhhatarai, Barun
    Repetto, Emanuela
    Guerrero, Miguel
    Riley, Sean
    Brown, Steven J.
    Kohno, Yasushi
    Roberts, Edward
    Schuerer, Stephan C.
    Rosen, Hugh
    ACS CHEMICAL BIOLOGY, 2012, 7 (12) : 1975 - 1983
  • [36] BML-241, a specific S1P3 receptor antagonist?
    Jongsma, M
    Hendriks, MC
    Mathy, MJ
    Michel, MC
    Peters, SLM
    Alewijnse, AE
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 373 (01) : 94 - 94
  • [37] Activation of the S1P3 Receptors is Responsible for S1P-mediated RhoA Activation and Cardioprotection
    Yung, Bryan S.
    Xiang, Sunny Y.
    Purcell, Nicole
    Rosen, Hugh
    Chun, Jerold
    Brown, Joan Heller
    Miyamoto, Shigeki
    CIRCULATION RESEARCH, 2015, 117
  • [38] The role of sphingosine kinase isoforms and receptors S1P1, S1P2, S1P3, and S1P5 in primary, secondary, and recurrent glioblastomas
    Quint, Karl
    Stiel, Norbert
    Neureiter, Daniel
    Schlicker, Hans Ulrich
    Nimsky, Christopher
    Ocker, Matthias
    Strik, Herwig
    Kolodziej, Malgorzata Anna
    TUMOR BIOLOGY, 2014, 35 (09) : 8979 - 8989
  • [39] Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling
    Gatfield, John
    Monnier, Lucile
    Studer, Rolf
    Bolli, Martin H.
    Steiner, Beat
    Nayler, Oliver
    CELLULAR SIGNALLING, 2014, 26 (07) : 1576 - 1588
  • [40] Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses
    Demont, Emmanuel H.
    Bailey, James M.
    Bit, Rino A.
    Brown, Jack A.
    Campbell, Colin A.
    Deeks, Nigel
    Dowell, Simon J.
    Eldred, Colin
    Gaskin, Pam
    Gray, James R. J.
    Haynes, Andrea
    Hirst, David J.
    Holmes, Duncan S.
    Kumar, Umesh
    Morse, Mary A.
    Osborne, Greg J.
    Renaux, Jessica F.
    Seal, Gail A. L.
    Smethurst, Chris A.
    Taylor, Simon
    Watson, Robert
    Willis, Robert
    Witherington, Jason
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (03) : 1003 - 1020